Patents by Inventor Xizhang Sun

Xizhang Sun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC NUCLEASE COMPOSITIONS AND METHODS
    Publication number: 20230057085
    Abstract: Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
    Type: Application
    Filed: March 16, 2022
    Publication date: February 23, 2023
    Inventors: Jeffrey A. Ledbetter, Martha Hayden-Ledbetter, Keith Elkon, Xizhang Sun
  • Therapeutic nuclease compositions and methods
    Patent number: 11306297
    Abstract: Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
    Type: Grant
    Filed: August 17, 2017
    Date of Patent: April 19, 2022
    Assignee: University of Washington
    Inventors: Jeffrey A. Ledbetter, Martha Hayden-Ledbetter, Keith Elkon, Xizhang Sun
  • Therapeutic Nuclease Compositions and Methods
    Publication number: 20210395711
    Abstract: Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
    Type: Application
    Filed: May 19, 2021
    Publication date: December 23, 2021
    Inventors: Jeffrey A. Ledbetter, Martha Hayden-Ledbetter, Keith Elkon, Xizhang Sun
  • Therapeutic nuclease compositions and methods
    Patent number: 11034944
    Abstract: Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: June 15, 2021
    Assignee: University of Washington
    Inventors: Jeffrey A. Ledbetter, Martha Hayden-Ledbetter, Keith Elkon, Xizhang Sun
  • Therapeutic Nuclease Compositions and Methods
    Publication number: 20190119660
    Abstract: Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
    Type: Application
    Filed: December 21, 2018
    Publication date: April 25, 2019
    Inventors: Jeffrey A. Ledbetter, Martha Hayden-Ledbetter, Keith Elkon, Xizhang Sun
  • Therapeutic nuclease compositions and methods
    Patent number: 10202588
    Abstract: Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
    Type: Grant
    Filed: April 27, 2012
    Date of Patent: February 12, 2019
    Assignee: The University of Washington
    Inventors: Jeffrey A. Ledbetter, Martha Hayden-Ledbetter, Keith Elkon, Xizhang Sun
  • Therapeutic Nuclease Compositions and Methods
    Publication number: 20180187174
    Abstract: Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
    Type: Application
    Filed: August 17, 2017
    Publication date: July 5, 2018
    Inventors: Jeffrey A. Ledbetter, Martha Hayden-Ledbetter, Keith Elkon, Xizhang Sun
  • Therapeutic nuclease compositions and methods
    Patent number: 10000745
    Abstract: Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
    Type: Grant
    Filed: January 19, 2015
    Date of Patent: June 19, 2018
    Assignee: University of Washington
    Inventors: Jeffrey A. Ledbetter, Martha Hayden-Ledbetter, Keith Elkon, Xizhang Sun
  • Therapeutic nuclease compositions and methods
    Patent number: 9790479
    Abstract: Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
    Type: Grant
    Filed: October 16, 2014
    Date of Patent: October 17, 2017
    Assignee: University of Washington
    Inventors: Jeffrey A. Ledbetter, Martha Hayden-Ledbetter, Keith Elkon, Xizhang Sun
  • Therapeutic Nuclease Compositions and Methods
    Publication number: 20150152399
    Abstract: Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
    Type: Application
    Filed: January 19, 2015
    Publication date: June 4, 2015
    Inventors: Jeffrey A. Ledbetter, Martha Hayden-Ledbetter, Keith Elkon, Xizhang Sun
  • THERAPEUTIC NUCLEASE COMPOSITIONS AND METHODS
    Publication number: 20150037871
    Abstract: Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
    Type: Application
    Filed: October 16, 2014
    Publication date: February 5, 2015
    Inventors: Jeffrey A. Ledbetter, Martha Hayden-Ledbetter, Keith Elkon, Xizhang Sun
  • Therapeutic nuclease compositions and methods
    Patent number: 8937157
    Abstract: Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
    Type: Grant
    Filed: February 6, 2014
    Date of Patent: January 20, 2015
    Assignee: University of Washington
    Inventors: Jeffrey A. Ledbetter, Martha Hayden-Ledbetter, Keith Elkon, Xizhang Sun
  • Therapeutic nuclease compositions and methods
    Patent number: 8841416
    Abstract: Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
    Type: Grant
    Filed: August 3, 2011
    Date of Patent: September 23, 2014
    Assignee: University of Washington
    Inventors: Jeffrey A. Ledbetter, Martha Hayden-Ledbetter, Keith Elkon, Xizhang Sun
  • THERAPEUTIC NUCLEASE COMPOSITIONS AND METHODS
    Publication number: 20140227269
    Abstract: Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
    Type: Application
    Filed: April 22, 2014
    Publication date: August 14, 2014
    Applicant: University of Washington
    Inventors: Jeffrey A. Ledbetter, Martha Hayden-Ledbetter, Keith Elkon, Xizhang Sun
  • Therapeutic Nuclease Compositions and Methods
    Publication number: 20140178379
    Abstract: Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
    Type: Application
    Filed: February 6, 2014
    Publication date: June 26, 2014
    Applicant: University of Washington
    Inventors: Jeffrey A. Ledbetter, Martha Hayden-Ledbetter, Keith Elkon, Xizhang Sun
  • Therapeutic Nuclease Compositions and Methods
    Publication number: 20140044711
    Abstract: Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
    Type: Application
    Filed: April 27, 2012
    Publication date: February 13, 2014
    Applicant: UNIVERSITY OF WASHINGTON
    Inventors: Jeffrey A. Ledbetter, Martha Hayden-Ledbetter, Keith Elkon, Xizhang Sun
  • THERAPEUTIC NUCLEASE COMPOSITIONS AND METHODS
    Publication number: 20130089546
    Abstract: Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
    Type: Application
    Filed: November 2, 2010
    Publication date: April 11, 2013
    Applicant: UNIVERSITY OF WASHINGTON
    Inventors: Jeffrey A. Ledbetter, Martha Hayden-Ledbetter, Keith Elkon, Xizhang Sun
  • THERAPEUTIC NUCLEASE COMPOSITIONS AND METHODS
    Publication number: 20120225066
    Abstract: Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
    Type: Application
    Filed: August 3, 2011
    Publication date: September 6, 2012
    Inventors: Jeffrey A. Ledbetter, Martha Hayden-Ledbetter, Keith Elkon, Xizhang Sun